A source can help correct a claim that misstates a finding

The exact sentence and its source help identify an error

The four medicines started with different goals, and researchers still test new uses. A wrong reference or changed approval can affect how you understand a treatment. A claim can also go beyond the people who took part. Semaglutide, tirzepatide, tesamorelin and bremelanotide each need that distinction kept clear.

You can send the page address, exact sentence and the supporting source. A link or full study reference helps locate the finding. Write to Editorial mailbox: editors@fdapeptide.com with those details. The study or official source needs to support the correction being requested.

The editor can check a claim while your doctor considers your health

This mailbox handles questions and corrections about the guide's treatment claims. The editor can't assess symptoms or decide which medicine to use, and can't give treatment instructions. Your doctor can consider health questions with your medical history. The editor can't judge whether treatment fits you or locate sellers either.

Study errors, wrong references and wording that is hard to follow receive priority, while requests for advertisements, product reviews or help finding products aren't accepted through this guide's correction mailbox. The editor may correct a claim after checking the source you send. A reply or a date for a change isn't guaranteed.

For an approval error, name the medicine, the use and the people covered. Include the date and wording in the official source. For a study error, explain the people tested and what happened with each treatment. Those details help distinguish a changed approval from a new experiment, another proposed use or a claim extending beyond the findings.